Aurinia Pharmaceuticals (IKAP) Revenue
1 Followers
Aurinia Pharmaceuticals Revenue
Aurinia Pharmaceuticals had a revenue of 83.70M in the quarter ending Sep 30, 2026, with 0.58%. This bring the company's revenue in the last twelve months to 321.74M, Increased 3.28%. In the fiscal year ending Dec 31, 2025, Aurinia Pharmaceuticals had annual revenue of 283.06M with 20.38% growth.
- Revenue (ttm)
- 321.74M
- Revenue Growth
- 15.36%
- P/S Ratio
- 6.97
- Revenue/Employee
- EUR 2,211,367
- Employees
- 128
- Market Cap
- EUR 1.97B
Revenue Chart
Aurinia Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 283.06M | 47.92M | 20.38% |
| Dec 31, 2024 | 235.13M | 59.62M | 33.97% |
| Dec 31, 2023 | 175.51M | 41.48M | 30.95% |
| Dec 31, 2022 | 134.03M | 88.42M | 193.89% |
| Dec 31, 2021 | 45.60M | -4.51M | -9.00% |
| Dec 31, 2020 | 50.12M | 49.80M | 15660.38% |
| Dec 31, 2019 | 318.00K | -145.00K | -31.32% |
| Dec 31, 2018 | 463.00K | 43.00K | 10.24% |
| Dec 31, 2017 | 420.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.